Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy - Test2 - elhamkhani - TriplyDB

Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy

Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy

http://www.wikidata.org/entity/Q27014919

about

The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease Oxidized cholesterol as the driving force behind the development of Alzheimer's disease Neuroprotection via Reduction in Stress: Altered Menstrual Patterns as a Marker for Stress and Implications for Long-Term Neurologic Health in Women A Bacterial Component to Alzheimer’s-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders?Synonymous variants in HTRA1 implicated in AMD susceptibility impair its capacity to regulate TGF-β signaling.Alzheimer's disease and infections, where we stand and where we go.Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk.An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.Exercise-mimetic AICAR transiently benefits brain function.A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling.Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses.Neuroprotective Effects of Aged Garlic Extract on Cognitive Dysfunction and Neuroinflammation Induced by β-Amyloid in Rats.Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.The Role of TDP-43 in Alzheimer's Disease.The Role of PGRN in Alzheimer's Disease.Polymorphonuclear Neutrophil Functions are Differentially Altered in Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease Patients.The Lipoxygenases: Their Regulation and Implication in Alzheimer's Disease.Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease.Inflammatory Response in the CNS: Friend or Foe?Astrocytes: inexplicable cells in neurodegeneration.Oral inflammation and infection, and chronic medical diseases: implications for the elderly.Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review.Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease.Plant polyphenols as inhibitors of NF-κB induced cytokine production-a potential anti-inflammatory treatment for Alzheimer's disease?Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta.Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration.Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer's Disease.The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.Alzheimer's disease and cytokine IL-10 gene polymorphisms: is there an association?Depiction of microglial activation in aging and dementia: Positron emission tomography with [11C]DPA713 versus [11C]( R)PK11195.Alzheimer's Disease, Oligomers, and Inflammation.

P2860

Q26750987-D5F1258F-D125-47AA-8FB1-7150C6C87F3A Q26781090-FB285E7E-FC61-4E18-A1DB-ADBB2F470FAD Q27023315-E8FB1D5E-92DB-4B0F-8689-D959B50D1970 Q28072386-BD7F7F05-9860-4BE7-9AE5-D27ACA056B48 Q29248210-B674424A-2C24-4632-852E-DA7DB94DA7C7 Q30235369-877182D9-4219-42AE-872B-C8E46BFDF998 Q30362129-9CCDB6D8-E262-4B6F-AB9C-17381FD62F51 Q30378420-C4DF2732-B24E-4A3E-81A8-B619AD8715D1 Q34753579-A5CB4A92-C202-4FBB-AB4D-4DA93C0D06C3 Q35667387-0DE438FA-2275-4B9C-BD79-F84892851F27 Q35733491-6835C578-69BD-4836-98C7-B85CC47EF89E Q35907609-166F3AB3-93B2-4B36-9798-2076B9B2F44A Q35957099-D57D79A6-C631-4B62-9BAA-87D6E426D619 Q35990600-AD8ACACC-3DB0-4CA2-A65A-CDA5759E2B10 Q36027275-4E14D863-36D4-4CA8-AEB3-3F3C48D0078E Q36210852-F799ABAE-8622-429E-8F15-5A8398D05EB5 Q36326816-2B6AAF47-903F-4499-BC06-DDC4830F7495 Q36546334-F6A03243-FB9E-44A9-B8B5-16235FDEBC6B Q37394743-AAAF548C-E159-45E9-927F-7AE38E9C5F6C Q37576743-C352448B-1F99-40CE-954F-66C77391A03B Q37628345-B24D9993-D9AF-4EB6-8541-D2555B601CC4 Q37630548-4284B711-9299-4D47-9250-5A6F495C6381 Q38529627-08A69851-9DDF-470A-80A6-7DD8B5D34D17 Q38555411-ABAA0973-04A0-4771-83B9-6A89F4530743 Q38640751-EFF85366-2274-45FC-BF91-FB4E37B8825D Q38671719-6BCCEA61-4149-418B-A5DF-873AC905431B Q38693735-5B5C1BF5-134F-4DE1-9890-81A415993484 Q38790379-BBED0517-AED1-4763-9B63-2938F9CBD493 Q38795492-E1E1BDAF-CDDC-4C72-A0E7-9C2D6C1721AA Q38921866-F53ACCB2-7DF9-4C58-9A77-69ABA9B728D5 Q39009840-861F7950-D2FC-426D-A614-FE83B12428ED Q39021109-774EEFA4-BC0B-4A2A-868A-D76EAF585A50 Q42003365-EA122884-F2F4-4A77-A620-6CF73334EF4B Q42085409-E39547A9-B5A4-402E-A0FA-9A418E657BEC Q42245222-02665163-9B76-4805-8497-CCF09E9F9D0D Q45741541-9D34ED27-416B-4435-8061-3D4C3704CA2F Q46251905-2B968C7F-29CD-4094-BA7E-88D8218B7148 Q47700520-2FACACD1-9566-4878-B369-78A3CA6EA99C Q48791445-F5D8C5AB-18BE-4CD8-8C18-B7BF3262A1B7 Q52644596-B866A680-0EE9-4586-B1AE-CC8CEE93487E

P2860

Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy

http://www.wikidata.org/entity/Q27014919

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Neuroinflammation in Alzheimer ...... arget for personalized therapy

@ast

Neuroinflammation in Alzheimer ...... arget for personalized therapy

@en

Neuroinflammation in Alzheimer ...... arget for personalized therapy

@nl

type

label

Neuroinflammation in Alzheimer ...... arget for personalized therapy

@ast

Neuroinflammation in Alzheimer ...... arget for personalized therapy

@en

Neuroinflammation in Alzheimer ...... arget for personalized therapy

@nl

prefLabel

Neuroinflammation in Alzheimer ...... arget for personalized therapy

@ast

Neuroinflammation in Alzheimer ...... arget for personalized therapy

@en

Neuroinflammation in Alzheimer ...... arget for personalized therapy

@nl

P1433

Q27014919-ECE984DC-179C-42B3-A362-F3342D66C46F

P1476

Q27014919-B0AAFD22-5291-4392-8137-538DAA47C6BF

P2093

Q27014919-560054E9-B106-4F3D-A977-0562B6262345

Q27014919-930E2494-C4DD-4AE9-9126-D549B84CDB4B

Q27014919-BCFCF0FE-6F7C-4CD9-8776-705D9683A361

P2860

Q27014919-00419EBD-293F-4350-B5DF-1EE57D6C7304

Q27014919-02DE8BAF-D4AC-425B-B317-320AE734264C

Q27014919-03DC409F-91B3-4B38-AD21-0D5498D1BB68

Q27014919-0464BA70-FFCE-4DE4-86DF-9056526A3937

Q27014919-09837037-BEFD-47CD-BCCF-EC8000FA9B94

Q27014919-09C56088-0CAA-4578-BE51-AADDADCE39F1

Q27014919-0AA44FC1-E973-47F9-9C62-8F6E50753F74

Q27014919-12708A30-48F1-4E36-AA7D-308B8A8D6FD8

Q27014919-13CEBF99-6DAE-436E-86E6-D643CEA43D11

Q27014919-142DF9D1-E247-4FBF-BBD0-9132EF7119ED

P304

Q27014919-C595FFF1-8346-48B1-820C-1494C69B1595

P31

Q27014919-C08E13C6-B77E-4617-BBE1-50CB6E1EA251

P3181

Q27014919-F27CD5AD-572F-43B8-936E-BE96702D0AA8

P356

Q27014919-3EF78E3A-CDDC-4781-AEE8-BC336806CB79

P407

Q27014919-A7EA211B-FBE8-424A-A02C-EBDA69FAC77E

P478

Q27014919-84CBBCA8-CB65-4CC7-BD9E-23D9B5887C62

P577

Q27014919-AF1BEC5D-E23D-4EE3-909D-7D91B1C83E3E

P698

Q27014919-C800B77A-A2F1-4A55-A791-BDD181F15D51

P921

Q27014919-69EA251A-2EA9-4B4E-9253-FDACE52AA90F

Q27014919-B4E4F65E-7180-487B-BD03-56770A7D528A

Q27014919-ea473456-b8d6-484f-96bc-9e2a6871526d

P932

Q27014919-8C75FF48-0979-414F-A2E2-3A2900817086

P3181

P356

J.NEUROSCIENCE.2014.09.061

P1433

P1476

Neuroinflammation in Alzheimer ...... arget for personalized therapy

@en

P2093

C.H. Latta

http://www.w3.org/2001/XMLSchema#string

D.M. Wilcock

http://www.w3.org/2001/XMLSchema#string

H.M. Brothers

http://www.w3.org/2001/XMLSchema#string

P2860

Exploring the full spectrum of macrophage activation

Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

A role for IgG immune complexes during infection with the intracellular pathogen Leishmania.

Inflammation and Alzheimer's disease

Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial

A meta-analysis of cytokines in Alzheimer's disease

Macrophages and their products in rheumatoid arthritis

No effect of one-year treatment with indomethacin on Alzheimer's disease progression: a randomized controlled trial

Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway

IL-4 attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro

P304

103-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2475866

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.NEUROSCIENCE.2014.09.061

http://www.w3.org/2001/XMLSchema#string

P407

P478

302

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25286385

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4602369

http://www.w3.org/2001/XMLSchema#string